Oragenics Issues Regulatory Notice On Audit Opinion Highlighting Going Concern Risk

Oragenics, Inc. announced that its audited consolidated financial statements for the fiscal year ending December 31, 2025 include an unqualified audit opinion with an explanatory paragraph highlighting concerns about the company’s ability to continue as a going concern. This disclosure was included in its Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission on March 16, 2026.

The announcement has been made in compliance with NYSE American LLC Company Guide Section 610(b), which requires companies to publicly disclose audit opinions that include a going-concern qualification. The company clarified that this notice does not indicate any revisions or amendments to its previously filed financial statements.

Oragenics emphasised that the disclosure is informational and aligns with regulatory requirements, with further details available in the financial statement footnotes within the 2025 Form 10-K filing.